For the Inventor, By the Inventor

Enter assignee name

Vasogen Ireland Limited

Calculating rank

USPTO Granted Patents = 30

% Expired Patents = 56.7

Forward Citations = 321

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Anthony E Bolton (12 out of 17 patents)

Taras Worona (8 out of 8 patents)

Duncan Newman (6 out of 18 patents)

4. Arkady Mandel (6 out of 15 patents)

5. Simon Treadwell (5 out of 38 patents)

6. Carlton Chong (4 out of 5 patents)

7. Thomas Blair Porter (4 out of 5 patents)

8. Sonya Mongomery (4 out of 4 patents)

9. Jeff Dayman (4 out of 7 patents)

10. Allen Muirhead (4 out of 4 patents)

11. Paul Moore (4 out of 4 patents)

12. Murray Voakes (4 out of 4 patents)

13. Liung Sen Liao (4 out of 4 patents)

14. Duncan John Stewart (2 out of 10 patents)

15. Jeffrey George Dayman (2 out of 14 patents)

Core Competencies:

Apoptosis

Synthetic Entities

Medical Dispensing

Mammalian Blood

Endothelial Dysfunction

Neurodegenerative Disorders

Atherosclerosis

Autoimmune Diseases

Chronic Lymphocytic Leukemia

Vasospastic Disorders

Graft Versus Host Disease

Stress Preconditioning

30 patents: Sort by Forward Citations

1. 7597906 - Apoptosis-mimicking synthetic entities and use thereof in medical treatment (2009-10-06),

2. 7361164 - Multi-outlet medical dispensing device (2008-04-22),

3. 7279156 - Apoptotic entities for use in treatment of endothelium dysfunction disorders (2007-10-09),

4. 7273586 - Apparatus and process for conditioning mammalian blood (2007-09-25),

5. 7255880 - Treatment of endothelin-related disorders (2007-08-14),

6. 7250137 - Apparatus and process for conditioning mammalian blood (2007-07-31),

7. 7223391 - Method for treating mammals with modified mammalian blood (2007-05-29),

8. 7153649 - Treatment of congestive heart failure (2006-12-26),

9. 7132285 - Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders (2006-11-07),

10. 7128873 - Apparatus and process for conditioning mammalian blood (2006-10-31),

11. 7125897 - Combined therapies for atherosclerosis treatment (2006-10-24),

12. 7122208 - Compositions containing apoptotic entities (2006-10-17),

13. 6986888 - Method for treating mammals with modified mammalian blood (2006-01-17),

14. 6953591 - Apoptosis-mimicking synthetic entities and use thereof in medical treatment (2005-10-11),

15. D508995 - Syringe adaptor (2005-08-30),

Company Overview

Vasogen Ireland Limited is a biotechnology company focused on developing innovative therapies for chronic inflammatory diseases. The organization specializes in advanced medical technologies aimed at enhancing patient outcomes through targeted treatment approaches. With a commitment to research and development, Vasogen leverages its expertise in immunology and cellular therapies to address unmet medical needs. The company operates primarily within the European healthcare landscape, contributing to the advancement of therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

30 Patents

#2 in

#89 in Ireland

#21,924 in the World

Vasogen Ireland Limited

Forward Citations = 321

40 inventors:

Anthony E Bolton (12 out of 17 patents)

Taras Worona (8 out of 8 patents)

Duncan Newman (6 out of 18 patents)

4. Arkady Mandel (6 out of 15 patents)

5. Simon Treadwell (5 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vasogen Ireland Limited. Retrieved from https://idiyas.com/company/vasogen-ireland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…